MRI appearances of uterine malignant mixed müllerian tumors

American Journal of Roentgenology

Volumn 195, Issue 5, 2010, Pages 1268-1275

  Bharwani, Nishat ^a   Newland, Anwen ^a   Tunariu, Nina ^b   Babar, Syed ^b   Sahdev, Anju ^a   Rockall, Andrea G ^a   Reznek, Rodney H ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Dynamic contrast enhanced MRI; Endometrial adenocarcinoma; Malignant mixed m llerian tumors; MRI

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTRAST ENHANCEMENT; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIXED MULLERIAN TUMOR; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME; UTERUS TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MIDDLE AGED; MIXED TUMOR, MULLERIAN; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 78649704513     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4419     Document Type: Article

References (35)

1. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004; 93:204-208
2. Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986; 76:399-402
3. Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 2005; 98:274-280
4. Vaidya AP, Horowitz NS, Oliva E, Halpern EF, Duska LR. Uterine malignant mixed müllerian tumors should not be included in studies of endometrial carcinoma. Gynecol Oncol 2006; 103: 684-687
5. Nielsen SN, Podratz KC, Scheithauer BW, O'Brien PC. Clinicopathologic analysis of uterine malignant mixed müllerian tumors. Gynecol Oncol 1989; 34:372-378
6. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 2004; 58:786-796 (Pubitemid 38221136)
7. Costa MJ, Tidd C, Willis D. Cervicovaginal cytology in carcinosarcoma [malignant mixed müllerian (mesodermal) tumor] of the uterus. Diagn Cytopathol 1992; 8:33-40
8. Rockall AG, Meroni R, Sohaib SA, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 2007; 17: 188-196 (Pubitemid 46213990)
9. Kato H, Kanematsu M, Furui T, et al. Carcinosarcoma of the uterus: radiologic-pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging. Magn Reson Imaging 2008; 26:1446-1450
10. Ohguri T, Aoki T, Watanabe H, et al. MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 2002; 12:2737-2742 (Pubitemid 36940387)
11. Rha SE, Byun JY, Jung SE, et al. CT and MRI of uterine sarcomas and their mimickers. AJR 2003; 181:1369-1374
12. Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. AJR 2001; 177:1307-1311
13. Shapeero LG, Hricak H. Mixed müllerian sarcoma of the uterus: MR imaging findings. AJR 1989; 153:317-319
14. Smith T, Moy L, Runowicz C. Müllerian mixed tumors: CT characteristics with clinical and pathologic observations. AJR 1997; 169:531-535
15. Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. RadioGraphics 2003; 23:403-424 (Pubitemid 37431272)
16. Takemori M, Nishimura R, Yasuda D, Sugimura K. Carcinosarcoma of the uterus: magnetic resonance imaging. Gynecol Obstet Invest 1997; 43: 139-141 (Pubitemid 27095926)
17. Tanaka YO, Tsunoda H, Minami R, Yoshikawa H, Minami M. Carcinosarcoma of the uterus: MR findings. J Magn Reson Imaging 2008; 28:434-439
18. Teo SY, Babagbemi KT, Peters HE, Mortele KJ. Primary malignant mixed müllerian tumor of the uterus: findings on sonography, CT, and gadolinium- enhanced MRI. AJR 2008; 191:278-283
19. Umesaki N, Tanaka T, Miyama M, Ogita S, Ochi H. Combined diagnostic imaging of uterine carcinosarcoma: a case report. Int J Gynecol Cancer 2000; 10:425-428
20. Yamashita Y, Takahashi M, Miyazaki K, Okamura H. Contrast-enhanced MR imaging of malignant mixed müllerian tumor of the uterus. AJR 1993; 160:1150-1151 (Pubitemid 23141277)
21. Worthington JL, Balfe DM, Lee JK, et al. Uterine neoplasms: MR imaging. Radiology 1986; 159: 725-730
22. Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 2005; 30:626-636 (Pubitemid 41446684)
23. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105:103-104
24. Prat J. FIGO Committee on Gynecologic Oncology. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009; 104:177-178 [Erratum in Int J Gynaecol Obstet 2009;106:277]
25. Carrington BM. Lymph node metastases. In: Husband JE, Reznek RH, eds. Imaging in oncology. London: Taylor and Francis, 2004:999-1022
26. Rosai J. Female reproductive system. In: Rosai J, ed. Rosai and Ackerman's surgical pathology. St. Louis, MO: Mosby, 2004:1483-1761
27. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen. Lancet 2000; 356: 881-887
28. Curtis RE, Freedman DM, Sherman ME, Fraumeni JF Jr. Risk of malignant mixed müllerian tumors after tamoxifen therapy for breast cancer. J Natl Cancer Inst 2004; 96:70-74
29. Huang YT, Huang KG, Ueng SH, Shaw SW. Irradiation- induced uterine malignant mixed müllerian tumor. Taiwan J Obstet Gynecol 2006; 45: 353-355
30. Sala E, Crawford R, Senior E, et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 2009; 19:141-146
31. Sala E, Wakely S, Senior E, Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. AJR 2007; 188:1577-1587
32. McMeekin DS, Lashbrook D, Gold M, et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001; 82:375-379
33. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40:55-65
34. Tozzi R, Malur S, Koehler C, Schneider A. Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 2005; 97:4-9
35. Namimoto T, Yamashita Y, Awai K, et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2009; 19:2756-2764